Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy Lars BørtyRasmus F. BrøndumMartin Bøgsted Original Paper 26 August 2022 Pages: 853 - 865
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France Manon BelhassenOlivier HanonNicolas Danchin Original Paper Open access 28 August 2022 Pages: 867 - 875
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study Tonya Moen HansenKnut StavemKim Rand Original Paper Open access 02 September 2022 Pages: 877 - 884
Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients Chen-Wei PanJun-Yi HePei Wang Original Paper 09 September 2022 Pages: 885 - 893
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK Adie ViljoenBarrie ChubbStephen C. Bain Original Paper Open access 17 September 2022 Pages: 895 - 907
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries Xiao LiJoke BilckeALIC4Etrial investigators Original Paper Open access 22 September 2022 Pages: 909 - 922
Do mobile hospital teams in residential aged care facilities increase health care efficiency: an evaluation of French residential care policy Anne Penneau Original Paper 22 September 2022 Pages: 923 - 937
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand Suzi ClaflinJulie A. CampbellBruce V. Taylor Original Paper Open access 23 September 2022 Pages: 939 - 950
The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses? Ângela Jornada BenJohanna M. van DongenJudith E. Bosmans Original Paper Open access 26 September 2022 Pages: 951 - 965
Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks Meg Perry-DuxburySebastian HimmlerWerner Brouwer Original Paper Open access 28 September 2022 Pages: 967 - 986
The application of discrete choice experiments eliciting young peoples’ preferences for healthcare: a systematic literature review Galina WilliamsIrina Kinchin Original Paper Open access 28 September 2022 Pages: 987 - 998
Does competition improve hospital performance: a DEA based evaluation from the Netherlands Peter DohmenMartin van IneveldJoris van de Klundert Original Paper Open access 04 October 2022 Pages: 999 - 1017